ALEPH-2
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | Pharmacology | PiHKAL | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | dot-2aleph2 | — | 2,5-DIMETHOXY-4-ETHYLTHIOAMPHETAMINE | ≠ |
| Safety | ||||
| Dose · Oral | ||||
| Common | — | — | 4–8 mg | |
| Duration | ||||
| Onset | 40–120 minutes | — | — | |
| Total | 6–18 hours | — | 8–16 hours | ≠ |
| After-effects | 12–24 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | Cytochrome P450 1B1Cytochrome P450 1A1 | — | |
Duration at a glance
Total duration on one shared scale.
TripSit summary
A very rare Phenethylamine, also known as DOT-2, it is the DOx analogue of 2C-T-2. Very little human use recorded. Described as being quite long and highly visual. Likely to be potent, with a reported threshold dose of 3mg.
PiHKAL summary
Like the rest of its family, this one is strikingly unpredictable, with no reliable relationship between dose and response. One person sank into a withdrawn, near-fetal state with lasting amnesia at just 4 mg, while another felt barely a threshold at twice that amount.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.